Author/Authors :
Ghazi, Ala Oral and Maxillofacial Diseases Research Center - Mashhad University of Medical Sciences - Mashhad, Iran , Dalirsani, Zohreh Oral and Maxillofacial Diseases Research Center - Mashhad University of Medical Sciences - Mashhad, Iran , Pakfetrat, Atessa Oral and Maxillofacial Diseases Research Center - Mashhad University of Medical Sciences - Mashhad, Iran , Delavarian, Zahra Oral and Maxillofacial Diseases Research Center - Mashhad University of Medical Sciences - Mashhad, Iran , Abdollahnejad, Marzieh , Banihashemi, Elham , Hashemy, Seyed Isaac Mashhad University of Medical Sciences - Mashhad, Iran , Vazifeh Mostaan, Leila Cancer Research Center - Mashhad University of Medical Sciences - Mashhad, Iran , Fani Pakdel, Azar Cancer Research Center - Mashhad University of Medical Sciences - Mashhad, Iran
Abstract :
Background: Head and neck squamous cell carcinoma (HNSCC) is the sixth common cancer worldwide. A hallmark of cancer progression
is degradation of the extracellular matrix by matrix metalloproteinases (MMPs) that allows cancer cells to invade the surrounding
tissue.
Objectives: The purpose of this studywasto evaluate the levels of MMP-2and9inserumandsalivary of HNSCCpatientsandcompare
it with a healthy group.
Methods: Twenty patients with newly diagnosed HNSCC, who had not received any treatment, referred to Omid and Ghaem hospitals,
Mashhad, Iran, and twenty healthy controls were voluntarily included in this study. Salivary and blood samples were collected
from both groups and the concentration of MMP-2 and MMP-9 were measured by enzyme-linked immunosorbent assay (ELISA).
Statistical analysis was performed by SPSS using Student t-test or Mann-Whitney with significance level of 0.05.
Results: In cancer patients, the serum level of MMP-9was significantly higher than that of in the healthy group (P< 0.001). However,
salivary MMP-9 was higher in cancer patients, this difference was not significant (P = 0.736). There was no significant difference
between the study groups for the levels of serum (P = 0.283) and salivary MMP-2 (P = 0.764). There was a correlation between salivary
and serum levels of both markers in cancer patients (P = 0.046 and P = 0.011 for MMP-2 and MMP-9, respectively), on the contrary,
there was not a correlation between them in the healthy controls (P = 0.628 and P = 0.064, for MMP-2 and MMP-9, respectively). A
direct correlation between the salivary level of MMP-9 and tumor grade was also detected (P = 0.045).
Conclusions: The salivary analysis indicates that an altered composition forMMPsin HNSCC, suggesting a potential diagnostic tool
for oral cancer. The serum level of MMP-9 appears to be a reliable marker for early diagnosis in HNSCC patients.
Keywords :
Head and Neck Squamous Cell Carcinoma , Matrix Metalloproteinase-2 , Matrix Metalloproteinase-9 , Saliva Serum